Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.

Abstract

AIMS:

Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone inducing post-prandial insulin secretion. Glucagon-like peptide 1 levels were recently found to be increased in patients with acute myocardial infarction. Glucagon-like peptide 1 receptor agonists improve cardiovascular outcomes in patients with diabetes. The aim of this study was to assess the predictive capacity of GLP-1 serum levels for cardiovascular outcome in patients with myocardial infarction.

METHODS AND RESULTS:

In 918 patients presenting with myocardial infarction [321 ST-segment elevation myocardial infarction and 597 non-ST-segment elevation myocardial infarction (NSTEMI)] total GLP-1, N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and the Global Registry of Acute Coronary Events (GRACE) score were assessed at time of hospital admission. The primary composite outcome of the study was the first occurrence of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke. Kaplan-Meier survival plots and univariable Cox regression analyses found GLP-1 to be associated with adverse outcome [hazard ratio (HR) of logarithmized GLP-1 values: 6.29, 95% confidence interval (CI): 2.67-14.81; P < 0.0001]. After further adjustment for age, sex, family history of cardiovascular disease, smoking, diabetes, hypertension, hypercholesterinaemia, glomerular filtration rate (GFR) CKD-EPI, hs-CRP, hs-Troponin T, and NT-proBNP levels the HR remained significant at 10.98 (95% CI: 2.63-45.90; P = 0.0010). Time-dependent receiver operating characteristic curve analyses illustrated that GLP-1 levels are a strong indicator for early events. For events up to 30 days after admission, GLP-1 proved to be superior to other biomarkers including hs-Troponin T, GFR CKD-EPI, hs-CRP, and NT-proBNP. Adjustment of the GRACE risk estimate by addition of GLP-1 increased the area under the receiver operating characteristic curve over time in NSTEMI patients.

CONCLUSION:

In patients hospitalized for myocardial infarction, GLP-1 levels are associated with cardiovascular events.

• Authors: Florian Kahles, Marcia V Rückbeil, Robert W Mertens, Ann C Foldenauer, Maria C Arrivas, Julia Moellmann, Corinna Lebherz, Moritz Biener, Evangelos Giannitsis, Hugo A Katus, Nikolaus Marx, Michael Lehrke
• Journal: European heart journal (Eur Heart J) Vol. 41 Issue 7 Pg. 882-889 (02 14 2020) ISSN: 1522-9645 [Electronic] England
• PMID: 31620788 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: [email protected].

Chemical References

• Biomarkers
• Peptide Fragments
• Natriuretic Peptide, Brain
• Glucagon-Like Peptide 1

Topics

• Biomarkers
• Cardiovascular Diseases (etiology)
• Glucagon-Like Peptide 1
• Heart Disease Risk Factors
• Humans
• Myocardial Infarction
• Natriuretic Peptide, Brain
• Peptide Fragments
• Prognosis
• Risk Factors